Abstract
COVID-19 infection causes considerable morbidity and mortality, especially to those who are aged, have impaired renal function and are obese. We propose to examine the potential utility of oral activated charcoal with the hypothesis that such treatment would lower absorption of microbiome derived toxins and ameliorate systemic oxidant stress and inflammation.
All Keywords
【초록키워드】 COVID-19, Treatment, Inflammation, Stress, Infection, renal function, COVID-19 infection, Microbiome, morbidity and mortality, utility, Hypothesis, activated charcoal, obese, Absorption, toxin, charcoal, activated, cause, 【제목키워드】 COVID-19, outcome, IMPROVE, Can,
【초록키워드】 COVID-19, Treatment, Inflammation, Stress, Infection, renal function, COVID-19 infection, Microbiome, morbidity and mortality, utility, Hypothesis, activated charcoal, obese, Absorption, toxin, charcoal, activated, cause, 【제목키워드】 COVID-19, outcome, IMPROVE, Can,
{{{ 추상적인 }}}
COVID-19 감염은 특히 노인, 신장 기능 장애 및 비만인 사람들에게 상당한 이환율과 사망률을 유발합니다. 우리는 이러한 치료가 미생물군집 유래 독소의 흡수를 낮추고 전신 산화제 스트레스 및 염증을 개선한다는 가설과 함께 경구 활성탄의 잠재적 유용성을 조사할 것을 제안합니다.